{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:05:15Z","timestamp":1790039115828,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancerepidemiology.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.canep.2015.04.004","type":"journal-article","created":{"date-parts":[[2015,4,18]],"date-time":"2015-04-18T20:32:32Z","timestamp":1429389152000},"page":"382-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic impact of hepatitis C virus infection in patients with diffuse large B-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7675-0129","authenticated-orcid":false,"given":"Yi-Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cih-En","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Wen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hsien","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Tsung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Der","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.canep.2015.04.004_bib0200","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2141.1994.tb05036.x","article-title":"Hepatitis C virus infection in patients with non-Hodgkin's lymphoma","volume":"88","author":"Ferri","year":"1994","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.canep.2015.04.004_bib0205","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1182\/blood.V84.9.3047.3047","article-title":"Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia","volume":"84","author":"Pozzato","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.canep.2015.04.004_bib0210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4251\/wjgo.v4.i3.46","article-title":"HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: evidence and open questions","volume":"4","author":"Cox","year":"2012","journal-title":"World J Gastrointest Oncol"},{"issue":"9001","key":"10.1016\/j.canep.2015.04.004_bib0215","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0140-6736(96)91328-8","article-title":"HCV and non-Hodgkin lymphoma","volume":"347","author":"Pioltelli","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.canep.2015.04.004_bib0220","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1182\/blood-2002-10-3230","article-title":"Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study","volume":"102","author":"Mele","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canep.2015.04.004_bib0225","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Peveling-Oberhag","year":"2013","journal-title":"J Hepatol"},{"issue":"32","key":"10.1016\/j.canep.2015.04.004_bib0230","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.3748\/wjg.v20.i32.11054","article-title":"Hepatitis C virus and diffuse large B-cell lymphoma: pathogenesis, behavior and treatment","volume":"20","author":"Visco","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.canep.2015.04.004_bib0235","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1053\/j.gastro.2006.09.019","article-title":"Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH","volume":"131","author":"Nieters","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.canep.2015.04.004_bib0240","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.canep.2015.04.004_bib0245","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d\u2019Etude des Lymphomes de l\u2019Adulte programs","volume":"24","author":"Besson","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.canep.2015.04.004_bib0250","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.canep.2015.04.004_bib0255","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.canep.2015.04.004_bib0260","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3324\/haematol.2013.094318","article-title":"Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi","volume":"99","author":"Merli","year":"2014","journal-title":"Haematologica"},{"issue":"24","key":"10.1016\/j.canep.2015.04.004_bib0265","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","article-title":"Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis","volume":"116","author":"Ennishi","year":"2010","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.canep.2015.04.004_bib0270","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project","volume":"329","year":"1993","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.canep.2015.04.004_bib0275","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.canep.2015.04.004_bib0280","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.canep.2015.04.004_bib0285","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdu462","article-title":"A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma","author":"Mian","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canep.2015.04.004_bib0290","article-title":"A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and beta-microglobulin","author":"Melchardt","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.canep.2015.04.004_bib0295","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.canep.2015.04.004_bib0300","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.canep.2015.04.004_bib0305","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12185-011-0993-6","article-title":"Prognostic significance of absolute lymphocyte count at diagnosis of diffuse large B-cell lymphoma: a meta-analysis","volume":"95","author":"Feng","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.canep.2015.04.004_bib0310","doi-asserted-by":"crossref","DOI":"10.1111\/cas.12544","article-title":"Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy","author":"Hong","year":"2014","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.canep.2015.04.004_bib0315","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clml.2011.09.215","article-title":"Prognostic value of platelet count in diffuse large B-cell lymphoma","volume":"12","author":"Chen","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"10.1016\/j.canep.2015.04.004_bib0320","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/1042819031000083055","article-title":"Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma","volume":"44","author":"Tomita","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.canep.2015.04.004_bib0325","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/10428190701732861","article-title":"Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma","volume":"49","author":"Park","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.canep.2015.04.004_bib0330","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/annonc\/mdl131","article-title":"Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy","volume":"17","author":"Visco","year":"2006","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.canep.2015.04.004_bib0335","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)","volume":"9","author":"Pfreundschuh","year":"2008","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.canep.2015.04.004_bib0340","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00277-014-2031-2","article-title":"Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era","volume":"93","author":"Dalia","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.canep.2015.04.004_bib0345","article-title":"The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China","author":"Li","year":"2014","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.canep.2015.04.004_bib0350","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/01635581.2014.867065","article-title":"Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOP","volume":"66","author":"Park","year":"2014","journal-title":"Nutr Cancer"},{"issue":"3","key":"10.1016\/j.canep.2015.04.004_bib0355","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/10428190701809156","article-title":"Prognostic factors in patients with diffuse large B cell lymphoma: before and after the introduction of rituximab","volume":"49","author":"Ngo","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.canep.2015.04.004_bib0360","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1207\/S15327914nc392_8","article-title":"Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss","volume":"39","author":"McMillan","year":"2001","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.canep.2015.04.004_bib0365","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature","volume":"9","author":"Gupta","year":"2010","journal-title":"Nutr J"},{"issue":"1","key":"10.1016\/j.canep.2015.04.004_bib0370","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI114419","article-title":"Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia","volume":"85","author":"Brenner","year":"1990","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.canep.2015.04.004_bib0375","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.dld.2010.05.010","article-title":"HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens","volume":"43","author":"Marignani","year":"2011","journal-title":"Digest Liver Dis"},{"issue":"3","key":"10.1016\/j.canep.2015.04.004_bib0380","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3892\/or.2012.1883","article-title":"Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: a single center experience","volume":"28","author":"Nishikawa","year":"2012","journal-title":"Oncol Rep"},{"issue":"11","key":"10.1016\/j.canep.2015.04.004_bib0385","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00277-014-2138-5","article-title":"Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy","volume":"93","author":"Salah-Eldin","year":"2014","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.canep.2015.04.004_bib0390","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jclinpath-2014-202352","article-title":"MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma","volume":"67","author":"Augello","year":"2014","journal-title":"J Clin Pathol"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782115000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782115000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T02:25:23Z","timestamp":1598927123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782115000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1877782115000855"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2015.04.004","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of hepatitis C virus infection in patients with diffuse large B-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2015.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}